We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.49 | -5.68493150685 | 43.8 | 46.095 | 41.0069 | 655102 | 42.95827888 | CS |
4 | -12.65 | -23.4432913269 | 53.96 | 61.59 | 39.33 | 1140887 | 45.96789247 | CS |
12 | -11.52 | -21.8057921635 | 52.83 | 71.71 | 39.33 | 1167410 | 53.72163039 | CS |
26 | 5.89 | 16.6290231508 | 35.42 | 71.71 | 34.5125 | 852510 | 51.26510435 | CS |
52 | 33.26 | 413.167701863 | 8.05 | 71.71 | 7.79 | 865222 | 48.49297431 | CS |
156 | 26.81 | 184.896551724 | 14.5 | 71.71 | 5.65 | 350390 | 42.00838929 | CS |
260 | 7.31 | 21.5 | 34 | 71.71 | 5.65 | 318981 | 40.29058564 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions